16-88856712-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000512.5(GALNS):c.120+46A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.035 ( 98 hom., cov: 20)
Exomes 𝑓: 0.035 ( 168 hom. )
Consequence
GALNS
NM_000512.5 intron
NM_000512.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.348
Publications
0 publications found
Genes affected
GALNS (HGNC:4122): (galactosamine (N-acetyl)-6-sulfatase) This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]
TRAPPC2L (HGNC:30887): (trafficking protein particle complex subunit 2L) This gene encodes a protein that interacts with the tethering factor trafficking protein particle (TRAPP complex). TRAPP complexes mediate the contact between vescicles and target membranes, and thus, are involved in vescicle-mediated transport of proteins and lipids. The encoded protein is related to the X-linked trafficking protein particle complex 2. A related pseudogene is located on the X chromosome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
TRAPPC2L Gene-Disease associations (from GenCC):
- encephalopathy, progressive, early-onset, with episodic rhabdomyolysisInheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 16-88856712-T-G is Benign according to our data. Variant chr16-88856712-T-G is described in ClinVar as Benign. ClinVar VariationId is 1289536.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0543 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000512.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALNS | NM_000512.5 | MANE Select | c.120+46A>C | intron | N/A | NP_000503.1 | P34059 | ||
| GALNS | NM_001323544.2 | c.-33+46A>C | intron | N/A | NP_001310473.1 | ||||
| GALNS | NM_001323543.2 | c.-312+46A>C | intron | N/A | NP_001310472.1 | Q6YL38 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GALNS | ENST00000268695.10 | TSL:1 MANE Select | c.120+46A>C | intron | N/A | ENSP00000268695.5 | P34059 | ||
| GALNS | ENST00000568311.1 | TSL:1 | c.120+46A>C | intron | N/A | ENSP00000455006.1 | H3BNU2 | ||
| TRAPPC2L | ENST00000564365.5 | TSL:1 | c.-398+466T>G | intron | N/A | ENSP00000455447.1 | H3BPS1 |
Frequencies
GnomAD3 genomes AF: 0.0349 AC: 4449AN: 127420Hom.: 97 Cov.: 20 show subpopulations
GnomAD3 genomes
AF:
AC:
4449
AN:
127420
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0304 AC: 1357AN: 44702 AF XY: 0.0302 show subpopulations
GnomAD2 exomes
AF:
AC:
1357
AN:
44702
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0346 AC: 10393AN: 300556Hom.: 168 Cov.: 3 AF XY: 0.0326 AC XY: 5243AN XY: 160980 show subpopulations
GnomAD4 exome
AF:
AC:
10393
AN:
300556
Hom.:
Cov.:
3
AF XY:
AC XY:
5243
AN XY:
160980
show subpopulations
African (AFR)
AF:
AC:
613
AN:
8504
American (AMR)
AF:
AC:
325
AN:
14896
Ashkenazi Jewish (ASJ)
AF:
AC:
170
AN:
8554
East Asian (EAS)
AF:
AC:
420
AN:
15608
South Asian (SAS)
AF:
AC:
653
AN:
45986
European-Finnish (FIN)
AF:
AC:
878
AN:
15702
Middle Eastern (MID)
AF:
AC:
19
AN:
1126
European-Non Finnish (NFE)
AF:
AC:
6616
AN:
173796
Other (OTH)
AF:
AC:
699
AN:
16384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
494
987
1481
1974
2468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0350 AC: 4459AN: 127502Hom.: 98 Cov.: 20 AF XY: 0.0349 AC XY: 2136AN XY: 61196 show subpopulations
GnomAD4 genome
AF:
AC:
4459
AN:
127502
Hom.:
Cov.:
20
AF XY:
AC XY:
2136
AN XY:
61196
show subpopulations
African (AFR)
AF:
AC:
1919
AN:
34014
American (AMR)
AF:
AC:
334
AN:
12708
Ashkenazi Jewish (ASJ)
AF:
AC:
42
AN:
3082
East Asian (EAS)
AF:
AC:
91
AN:
4208
South Asian (SAS)
AF:
AC:
53
AN:
3698
European-Finnish (FIN)
AF:
AC:
311
AN:
7600
Middle Eastern (MID)
AF:
AC:
3
AN:
256
European-Non Finnish (NFE)
AF:
AC:
1629
AN:
59346
Other (OTH)
AF:
AC:
63
AN:
1784
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
202
404
607
809
1011
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
52
AN:
3218
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.